Simplex Trading
SEEL

Simplex Trading’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Simplex Trading’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-64
Closed -$167K – 11375
2022
Q1 		$206K Buy
64
+14
+28% +$60.2K ﹤0.01% 5115
2021
Q4 		$315K Buy
50
+41
+456% +$315K ﹤0.01% 4489
2021
Q3 		$95K Hold
9
– – ﹤0.01% 6695
2021
Q2 		$88K Buy
9
+1
+13% +$16.4K ﹤0.01% 6918
2021
Q1 		$148K Buy
+8
New +$93.4K ﹤0.01% 5203
2016
Q2 		– Hold
0
– – – 6582
2016
Q1 		– Hold
0
– – – 4324
2015
Q4 		– Hold
0
– – – 6296
2015
Q3 		– Hold
0
– – – 6323
2015
Q2 		– Hold
0
– – – 5991
2015
Q1 		– Hold
0
– – – 4652
2014
Q4 		– Hold
0
– – – 4336

Other funds holding SEEL

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Simplex Trading's SEEL Position: Q2 2022 in Review

Simplex Trading sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q2 2022, closing a stake of 64 shares — an estimated $167K sold.

Simplex Trading first reported a position in SEEL in Q1 2021 and held it in 5 quarters. The position peaked at $315K in Q4 2021. 65 funds tracked by Wall St. Rank hold SEEL as of Q2 2022.

  • Simplex Trading reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Simplex Trading sold 64 Seelos Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $167K.
  • Simplex Trading first reported a position in Seelos Therapeutics, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
  • Simplex Trading's Seelos Therapeutics, Inc. Common Stock position peaked at $315K in Q4 2021.
  • 65 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Simplex Trading's 13F filing for Q2 2022, filed 3 Aug 2022.